Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

The clinical relevance of in vitro synergistic activity of antibiotics for MDR Gram-negative infections: A systematic review.

Vardakas KZ, Athanassaki F, Pitiriga V, Falagas ME.

J Glob Antimicrob Resist. 2019 Jan 15. pii: S2213-7165(19)30011-6. doi: 10.1016/j.jgar.2019.01.004. [Epub ahead of print] Review.

PMID:
30658202
2.

Resistance to fosfomycin: Mechanisms, Frequency and Clinical Consequences.

Falagas ME, Athanasaki F, Voulgaris GL, Triarides NA, Vardakas KZ.

Int J Antimicrob Agents. 2019 Jan;53(1):22-28. doi: 10.1016/j.ijantimicag.2018.09.013. Epub 2018 Sep 27. Review.

PMID:
30268576
3.

An update on adverse drug reactions related to β-lactam antibiotics.

Vardakas KZ, Kalimeris GD, Triarides NA, Falagas ME.

Expert Opin Drug Saf. 2018 May;17(5):499-508. doi: 10.1080/14740338.2018.1462334. Epub 2018 Apr 18. Review.

PMID:
29633867
4.

Activity of TP-6076 against carbapenem-resistant Acinetobacter baumannii isolates collected from inpatients in Greek hospitals.

Falagas ME, Skalidis T, Vardakas KZ, Voulgaris GL, Papanikolaou G, Legakis N; Hellenic TP-6076 Study Group.

Int J Antimicrob Agents. 2018 Aug;52(2):269-271. doi: 10.1016/j.ijantimicag.2018.03.009. Epub 2018 Mar 17.

PMID:
29559273
5.

Temporal Trends (1999-2015) in the Impact Factor of Biomedical Journals Published by US and EU Scientific Societies.

Falagas ME, Kyriakidou M, Spais G, Argiti E, Vardakas KZ.

Rambam Maimonides Med J. 2018 Apr 19;9(2). doi: 10.5041/RMMJ.10332.

6.

Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: A systematic review and meta-analysis.

Vardakas KZ, Mavroudis AD, Georgiou M, Falagas ME.

J Infect. 2018 Apr;76(4):321-327. doi: 10.1016/j.jinf.2018.02.002. Epub 2018 Feb 8. Review.

PMID:
29428226
7.

Intravenous colistin combination antimicrobial treatment vs. monotherapy: a systematic review and meta-analysis.

Vardakas KZ, Mavroudis AD, Georgiou M, Falagas ME.

Int J Antimicrob Agents. 2018 Apr;51(4):535-547. doi: 10.1016/j.ijantimicag.2017.12.020. Epub 2017 Dec 27. Review.

PMID:
29288723
8.

Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials.

Vardakas KZ, Voulgaris GL, Maliaros A, Samonis G, Falagas ME.

Lancet Infect Dis. 2018 Jan;18(1):108-120. doi: 10.1016/S1473-3099(17)30615-1. Epub 2017 Nov 5.

PMID:
29102324
9.

The dilemma of monotherapy or combination therapy in community-acquired pneumonia.

Vardakas KZ, Trigkidis KK, Apiranthiti KN, Falagas ME.

Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12845. Epub 2017 Nov 9. Review.

PMID:
29027205
10.

Resistance phenotypes and susceptibility of contemporary Serratia isolates in the university hospital of Crete, Greece.

Samonis G, Vardakas KZ, Maraki S, Stamouli P, Mavromanolaki VE, Kofteridis DP, Falagas ME.

Infect Dis (Lond). 2017 Nov - Dec;49(11-12):847-853. doi: 10.1080/23744235.2017.1361546. Epub 2017 Aug 2.

PMID:
28768448
11.

Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.

Vardakas KZ, Voulgaris GL, Samonis G, Falagas ME.

Int J Antimicrob Agents. 2018 Jan;51(1):1-9. doi: 10.1016/j.ijantimicag.2017.05.016. Epub 2017 Jun 29. Review.

PMID:
28669836
12.

In vitro susceptibility and resistance phenotypes in contemporary Enterobacter isolates in a university hospital in Crete, Greece.

Maraki S, Vardakas KZ, Samonis G, Perdikis D, Mavromanolaki VE, Kofteridis DP, Falagas ME.

Future Microbiol. 2017 Jun;12:683-693. doi: 10.2217/fmb-2016-0216. Epub 2017 May 25.

PMID:
28540747
13.

Continuous or Extended Intravenous Administration of β-Lactam Antibiotics.

Falagas ME, Vardakas KZ.

Am J Respir Crit Care Med. 2017 Apr 15;195(8):1077-1078. doi: 10.1164/rccm.201610-2004LE. No abstract available.

PMID:
28409679
14.

Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.

Falagas ME, Skalidis T, Vardakas KZ, Legakis NJ; Hellenic Cefiderocol Study Group.

J Antimicrob Chemother. 2017 Jun 1;72(6):1704-1708. doi: 10.1093/jac/dkx049.

PMID:
28369471
15.

In vitro susceptibility and resistance phenotypes in contemporary Citrobacter isolates in a University Hospital in Crete, Greece.

Maraki S, Vardakas KZ, Mavromanolaki VE, Kyriakidou M, Spais G, Kofteridis DP, Samonis G, Falagas ME.

Infect Dis (Lond). 2017 Jul;49(7):532-539. doi: 10.1080/23744235.2017.1297896. Epub 2017 Mar 9.

PMID:
28276281
16.

Fluoroquinolones or macrolides in combination with β-lactams in adult patients hospitalized with community acquired pneumonia: a systematic review and meta-analysis.

Vardakas KZ, Trigkidis KK, Falagas ME.

Clin Microbiol Infect. 2017 Apr;23(4):234-241. doi: 10.1016/j.cmi.2016.12.002. Epub 2016 Dec 10. Review.

17.

Colistin loading dose: evaluation of the published pharmacokinetic and clinical data.

Vardakas KZ, Rellos K, Triarides NA, Falagas ME.

Int J Antimicrob Agents. 2016 Nov;48(5):475-484. doi: 10.1016/j.ijantimicag.2016.08.009. Epub 2016 Sep 28. Review.

PMID:
27743779
18.

Colistin versus polymyxin B for the treatment of patients with multidrug-resistant Gram-negative infections: a systematic review and meta-analysis.

Vardakas KZ, Falagas ME.

Int J Antimicrob Agents. 2017 Feb;49(2):233-238. doi: 10.1016/j.ijantimicag.2016.07.023. Epub 2016 Sep 16. Review.

PMID:
27686609
19.

The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?

Falagas ME, Mavroudis AD, Vardakas KZ.

Expert Rev Anti Infect Ther. 2016 Aug;14(8):747-63. doi: 10.1080/14787210.2016.1204911. Review.

PMID:
27400643
20.

Impact of oseltamivir use on the reduction of complications in patients with influenza: a prospective study.

Vardakas KZ, Theocharis G, Tansarli GS, Rafailidis P, Falagas ME.

Arch Virol. 2016 Sep;161(9):2511-8. doi: 10.1007/s00705-016-2941-5. Epub 2016 Jul 1.

PMID:
27368992

Supplemental Content

Loading ...
Support Center